Sicriptin 1.25 mg

Composition of Sicriptin 1.25 mg

Sicriptin 1.25 mg contains Bromocriptine (1.25mg). It belongs to the Dopamine agonist (ergot derivative) class of medicines.

Uses of Sicriptin 1.25 mg

• Treatment of hyperprolactinaemia (amenorrhoea
• galactorrhoea
• infertility)
• prolactinoma
• acromegaly (adjunct)
• Parkinson’s disease (adjunct)
• type 2 diabetes mellitus (where prescribed as bromocriptine quick-release)

Key benefits

• Lowers elevated prolactin levels
• Helps restore ovulation/menstrual regularity
• Reduces galactorrhoea
• Shrinks prolactin-secreting pituitary tumours
• Adjunct benefit in acromegaly/Parkinson’s as prescribed

How Sicriptin 1.25 mg works

Bromocriptine is an ergot-derived dopamine D2 receptor agonist. It inhibits prolactin release from the pituitary gland, reducing prolactin levels and related symptoms. Dopaminergic activity also helps improve motor symptoms in Parkinson’s disease and can improve glycaemic control with the quick-release formulation.

How to take Sicriptin 1.25 mg

Take orally exactly as prescribed, preferably with food to reduce nausea. Usually started at a low dose and increased gradually. Take at the same time each day; do not stop abruptly without medical advice.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

If you miss a dose of Sicriptin 1.25 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

If you take too much

An overdose of this medicine may cause nausea, vomiting and withdrawal bleeding. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Sicriptin 1.25 mg

Most side effects of Sicriptin are mild and settle as the body adjusts. Reported side effects include:

• Nausea
• vomiting
• dizziness
• headache
• abdominal discomfort
• constipation
• fatigue
• nasal congestion
• orthostatic hypotension
• drowsiness

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Sicriptin 1.25 mg

Warnings and precautions

May cause dizziness/low blood pressure—rise slowly from sitting/lying; avoid driving if drowsy. Use with caution in patients with cardiovascular disease, psychiatric disorders, liver impairment, or history of fainting. Rare risks include severe hypotension, hallucinations/impulse control disorders, and fibrotic complications with long-term/high-dose ergot derivatives. Not recommended for routine suppression of lactation; seek medical advice if postpartum hypertension or pre-eclampsia. Monitor prolactin/clinical response as advised.

Do not take Sicriptin if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for people with a history of blood clots, certain hormone-sensitive cancers, or active liver disease. Several are contraindicated in pregnancy.

Interactions with other medicines

Macrolide antibiotics (e.g., erythromycin, clarithromycin) and azole antifungals (increase levels), protease inhibitors, dopamine antagonists (metoclopramide, antipsychotics) may reduce effect, antihypertensives (additive hypotension), other ergot alkaloids/vasoconstrictors (additive adverse effects), CNS depressants/alcohol (increased drowsiness)

How to store Sicriptin 1.25 mg

Store below 25°C in a dry place, protected from light and moisture. Keep out of reach of children.

Expert advice for Sicriptin 1.25 mg

Sicriptin 1.25 Tablet is used to treat conditions caused by excess production of a natural hormone called prolactin such as infertility, or abnormal production of breast milk (galactorrhoea). It should be taken with or after food to avoid side effects such as nausea or indigestion. To lower the chance of feeling dizzy or passing out, rise slowly if you have been sitting or lying down. Use caution while driving or doing anything that requires concentration as Sicriptin 1.25 Tablet can cause dizziness and sleepiness. Do not take Sicriptin 1.25 Tablet if you are breastfeeding. Monitoring of blood pressure may be advised regularly during treatment with Sicriptin 1.25 Tablet.

Manufacturer and class

Manufacturer:

SERUM INTERNATIONAL LTD`

Therapeutic class:

Endocrine / Hormonal (anti-hyperprolactinaemia agent)

Drug class:

Dopamine agonist (ergot derivative)

Chemical class:

Lysergamides